id	sid	eid	entity	type
bptjm-46	1	1	berkeley pharma tech journal	ORG
bptjm-46	1	2	fasentin panitumumab	PERSON
bptjm-46	1	3	5	CARDINAL
bptjm-46	1	4	2023	CARDINAL
bptjm-46	1	5	2023	CARDINAL
bptjm-46	1	6	december 30	DATE
bptjm-46	1	7	2023	CARDINAL
bptjm-46	1	8	4.0	CARDINAL
bptjm-46	7	1	heyi fang	PERSON
bptjm-46	7	2	hailey guinto	PERSON
bptjm-46	7	3	harshita pinneboina 1	ORG
bptjm-46	9	1	as high as 90%	PERCENT
bptjm-46	11	1	70%	PERCENT
bptjm-46	12	1	one	CARDINAL
bptjm-46	21	1	berkeley pharma tech journal	ORG
bptjm-46	21	2	102	CARDINAL
bptjm-46	22	1	fasentin	ORG
bptjm-46	22	2	panitumumab	PERSON
bptjm-46	23	1	2	CARDINAL
bptjm-46	23	2	diseases3	GPE
bptjm-46	24	1	over 30 kg/m2	QUANTITY
bptjm-46	28	1	two	CARDINAL
bptjm-46	29	1	tissue4	GPE
bptjm-46	30	1	process5	PERSON
bptjm-46	31	1	reneau	GPE
bptjm-46	31	2	james et al	PERSON
bptjm-46	31	3	correlation6	PERSON
bptjm-46	32	1	gluconeogenesis6	PERSON
bptjm-46	34	1	hypothalamus7,8	GPE
bptjm-46	34	2	berkeley pharma tech journal	ORG
bptjm-46	34	3	103	CARDINAL
bptjm-46	37	1	decomposition9	ORG
bptjm-46	39	1	1	CARDINAL
bptjm-46	40	1	1	CARDINAL
bptjm-46	44	1	3	CARDINAL
bptjm-46	44	2	berkeley pharma tech journal	ORG
bptjm-46	44	3	104	CARDINAL
bptjm-46	44	4	t2dm.	ORG
bptjm-46	45	1	the pi3k/akt	ORG
bptjm-46	46	1	bloodstream12	PERSON
bptjm-46	47	1	approximately 34	CARDINAL
bptjm-46	47	2	used13	ORG
bptjm-46	49	1	around 5	CARDINAL
bptjm-46	49	2	only 12.5%	PERCENT
bptjm-46	49	3	pressure15	ORG
bptjm-46	50	1	warburg	GPE
bptjm-46	51	1	only 4	CARDINAL
bptjm-46	52	1	complex17	ORG
bptjm-46	54	1	body18	ORG
bptjm-46	56	1	1	CARDINAL
bptjm-46	57	1	berkeley pharma tech journal	ORG
bptjm-46	57	2	105	CARDINAL
bptjm-46	57	3	3	CARDINAL
bptjm-46	59	1	igfbp3	PERSON
bptjm-46	60	1	4.	CARDINAL
bptjm-46	60	2	panitumumab	PERSON
bptjm-46	60	3	two	CARDINAL
bptjm-46	64	1	3	CARDINAL
bptjm-46	64	2	glut1-4 and glut1421.	ORG
bptjm-46	65	1	glut4	PERSON
bptjm-46	65	2	tissue22	GPE
bptjm-46	66	1	glut4	PERSON
bptjm-46	67	1	glut4	PERSON
bptjm-46	68	1	glut4	PERSON
bptjm-46	70	1	berkeley pharma tech journal	ORG
bptjm-46	70	2	106	CARDINAL
bptjm-46	71	1	two	CARDINAL
bptjm-46	72	1	first	ORDINAL
bptjm-46	75	1	panitumumab25	GPE
bptjm-46	76	1	panitumumab	PERSON
bptjm-46	77	1	t2dm	ORG
bptjm-46	78	1	panitumumab	ORG
bptjm-46	78	2	replication27	GPE
bptjm-46	79	1	panitumumab	PERSON
bptjm-46	80	1	panitumumab	ORG
bptjm-46	81	1	cancer28	ORG
bptjm-46	82	1	secondly	ORDINAL
bptjm-46	82	2	glut4	PERSON
bptjm-46	83	1	fasentin	ORG
bptjm-46	83	2	2	CARDINAL
bptjm-46	84	1	firstly	ORDINAL
bptjm-46	84	2	fasentin	ORG
bptjm-46	84	3	glut4	PERSON
bptjm-46	85	1	ic50 value29	PERSON
bptjm-46	85	2	fasentin e	ORG
bptjm-46	86	1	secondly	ORDINAL
bptjm-46	86	2	fasentin presence	ORG
bptjm-46	86	3	cancer30	ORG
bptjm-46	87	1	fasentin	ORG
bptjm-46	87	2	berkeley pharma tech journal	ORG
bptjm-46	87	3	107 5	DATE
bptjm-46	87	4	4	CARDINAL
bptjm-46	87	5	2	CARDINAL
bptjm-46	89	1	2	CARDINAL
bptjm-46	96	1	4	CARDINAL
bptjm-46	101	1	two	CARDINAL
bptjm-46	102	1	4	CARDINAL
bptjm-46	102	2	2	CARDINAL
bptjm-46	102	3	berkeley pharma tech journal	ORG
bptjm-46	102	4	108 monocarboxylate	QUANTITY
bptjm-46	102	5	4	CARDINAL
bptjm-46	103	1	mct4	PERSON
bptjm-46	104	1	cb2	PERSON
bptjm-46	105	1	cb1	ORG
bptjm-46	105	2	cb2	PERSON
bptjm-46	108	1	d9-thc	ORG
bptjm-46	108	2	2005	DATE
bptjm-46	108	3	cb2	PERSON
bptjm-46	108	4	outcomes33	ORG
bptjm-46	115	1	berkeley pharma tech journal	ORG
bptjm-46	115	2	109	CARDINAL
bptjm-46	115	3	cb2	PERSON
bptjm-46	116	1	cb2	PRODUCT
bptjm-46	118	1	nk-kb	PERSON
bptjm-46	123	1	ability38	NORP
bptjm-46	126	1	mct4	PERSON
bptjm-46	126	2	gln339	CARDINAL
bptjm-46	128	1	63%	PERCENT
bptjm-46	128	2	cells39	PERSON
bptjm-46	130	1	mct4	PERSON
bptjm-46	131	1	mct4	PERSON
bptjm-46	133	1	mct4	PERSON
bptjm-46	134	1	berkeley pharma tech journal	ORG
bptjm-46	134	2	110	CARDINAL
bptjm-46	135	1	6	CARDINAL
bptjm-46	139	1	one	CARDINAL
bptjm-46	139	2	warburg	GPE
bptjm-46	141	1	2	CARDINAL
bptjm-46	141	2	1	CARDINAL
bptjm-46	141	3	igf-1	ORG
bptjm-46	143	1	two	CARDINAL
bptjm-46	143	2	1	CARDINAL
bptjm-46	143	3	2	CARDINAL
bptjm-46	144	1	mtorc1	PERSON
bptjm-46	144	2	mtoc1	PERSON
bptjm-46	146	1	mtorc1	PERSON
bptjm-46	147	1	berkeley pharma tech journal	ORG
bptjm-46	147	2	111	CARDINAL
bptjm-46	147	3	up to 53%	PERCENT
bptjm-46	148	1	45	CARDINAL
bptjm-46	151	1	igf-ir/ir	ORG
bptjm-46	151	2	akt	GPE
bptjm-46	151	3	erk	ORG
bptjm-46	152	1	mtor45	GPE
bptjm-46	153	1	72%	PERCENT
bptjm-46	153	2	2	CARDINAL
bptjm-46	153	3	2	CARDINAL
bptjm-46	155	1	igf-1	ORG
bptjm-46	157	1	1 or 5 mg/ml	QUANTITY
bptjm-46	157	2	approximately 20%	PERCENT
bptjm-46	157	3	20%	PERCENT
bptjm-46	157	4	35%44	DATE
bptjm-46	158	1	berkeley pharma tech journal	ORG
bptjm-46	158	2	112	CARDINAL
bptjm-46	160	1	igf-1	ORG
bptjm-46	161	1	daily	DATE
bptjm-46	161	2	igf-1	ORG
bptjm-46	164	1	40%	PERCENT
bptjm-46	165	1	80s ribosomes46	DATE
bptjm-46	168	1	proliferation47	PERSON
bptjm-46	169	1	80s	DATE
bptjm-46	172	1	mtorc1	PERSON
bptjm-46	173	1	cells49	ORG
bptjm-46	174	1	mcf-7 berkeley pharma tech journal	ORG
bptjm-46	174	2	113	CARDINAL
bptjm-46	181	1	three	CARDINAL
bptjm-46	181	2	panitumumab	ORG
bptjm-46	181	3	fasentin	ORG
bptjm-46	184	1	berkeley pharma tech journal	ORG
bptjm-46	184	2	114	CARDINAL
bptjm-46	184	3	1	CARDINAL
bptjm-46	185	1	2	CARDINAL
bptjm-46	186	1	tu h	ORG
bptjm-46	186	2	wen cp	GPE
bptjm-46	186	3	tsai	PERSON
bptjm-46	189	1	k134	GPE
bptjm-46	190	1	2018 jan 31	DATE
bptjm-46	192	1	3	CARDINAL
bptjm-46	192	2	kitabchi ae	PERSON
bptjm-46	192	3	umpierrez ge	PERSON
bptjm-46	192	4	miles jm	PERSON
bptjm-46	196	1	2009;32(7):1335-1343	CARDINAL
bptjm-46	199	1	ghoshal	ORG
bptjm-46	199	2	k.	PERSON
bptjm-46	199	3	chatterjee	GPE
bptjm-46	199	4	t.	GPE
bptjm-46	199	5	chowdhury	PERSON
bptjm-46	199	6	s. et al	PERSON
bptjm-46	201	1	biochemgenet 59	PERSON
bptjm-46	201	2	2021	CARDINAL
bptjm-46	202	1	5	CARDINAL
bptjm-46	202	2	reneau	GPE
bptjm-46	202	3	james et al	PERSON
bptjm-46	204	1	plos one	PERSON
bptjm-46	205	1	13,6	CARDINAL
bptjm-46	206	1	20	CARDINAL
bptjm-46	206	2	jun. 2018	DATE
bptjm-46	210	1	the international association for the study	ORG
bptjm-46	210	2	26,11 (2002	DATE
bptjm-46	210	3	1407-33	DATE
bptjm-46	211	1	doi:10.1038	ORG
bptjm-46	211	2	7	CARDINAL
bptjm-46	211	3	dimitriadis	PERSON
bptjm-46	211	4	george et al	PERSON
bptjm-46	214	1	93	CARDINAL
bptjm-46	214	2	2011	DATE
bptjm-46	214	3	doi:10.1016	GPE
bptjm-46	214	4	-germano l	PERSON
bptjm-46	214	5	vieira mndn	PERSON
bptjm-46	218	1	2019	DATE
bptjm-46	218	2	jan 14	DATE
bptjm-46	219	1	9	CARDINAL
bptjm-46	219	2	kennedy	PERSON
bptjm-46	219	3	gettys tw	PERSON
bptjm-46	219	4	watson p	PERSON
bptjm-46	221	1	j clin endocrinol metab	PERSON
bptjm-46	222	1	1997;82(4):1293-1300	CARDINAL
bptjm-46	224	1	wang	ORG
bptjm-46	224	2	guanyu	PERSON
bptjm-46	226	1	7,4 046015	DATE
bptjm-46	227	1	22	CARDINAL
bptjm-46	227	2	dec. 2010	DATE
bptjm-46	227	3	3975/7/4/046015 11	DATE
bptjm-46	228	1	gatenby	ORG
bptjm-46	228	2	r.	NORP
bptjm-46	228	3	gillies	PERSON
bptjm-46	228	4	r.	NORP
bptjm-46	229	1	nat rev	PERSON
bptjm-46	229	2	4	CARDINAL
bptjm-46	229	3	2004	DATE
bptjm-46	230	1	12	CARDINAL
bptjm-46	231	1	del puerto-nevado l	ORG
bptjm-46	231	2	santiago-hernandez	PERSON
bptjm-46	233	1	2019;13(9):1887-1897	DATE
bptjm-46	235	1	daoxiang et al	PERSON
bptjm-46	238	1	2015	DATE
bptjm-46	238	2	1335-48	DATE
bptjm-46	239	1	doi:10.1016	GPE
bptjm-46	239	2	14	CARDINAL
bptjm-46	240	1	neophytou cm	PERSON
bptjm-46	241	1	berkeley pharma tech journal	ORG
bptjm-46	241	2	115	CARDINAL
bptjm-46	243	1	2021;13(9):2053	CARDINAL
bptjm-46	244	1	2021	CARDINAL
bptjm-46	245	1	15	CARDINAL
bptjm-46	246	1	vander heiden	PERSON
bptjm-46	246	2	matthew g et al	PERSON
bptjm-46	248	1	new york	GPE
bptjm-46	248	2	n.y.	GPE
bptjm-46	249	1	324,5930	CARDINAL
bptjm-46	249	2	2009	DATE
bptjm-46	249	3	1029-33	DATE
bptjm-46	251	1	jogie-brahim	PERSON
bptjm-46	254	1	30,5	CARDINAL
bptjm-46	254	2	2009	DATE
bptjm-46	254	3	417	CARDINAL
bptjm-46	256	1	olson	PERSON
bptjm-46	256	2	j e pessin	PERSON
bptjm-46	258	1	annual	DATE
bptjm-46	259	1	16 (1996	DATE
bptjm-46	259	2	235	CARDINAL
bptjm-46	260	1	18	CARDINAL
bptjm-46	264	1	2010;122(3):158	CARDINAL
bptjm-46	264	2	doi:10.3810	GPE
bptjm-46	264	3	19	CARDINAL
bptjm-46	265	1	bell	ORG
bptjm-46	268	1	13,3 (1990	DATE
bptjm-46	268	2	198	CARDINAL
bptjm-46	269	1	20	CARDINAL
bptjm-46	269	2	shepherd	ORG
bptjm-46	270	1	glut4	PERSON
bptjm-46	271	1	1993	DATE
bptjm-46	271	2	22243	CARDINAL
bptjm-46	274	1	plos one	PERSON
bptjm-46	275	1	9 oct. 2014	TIME
bptjm-46	276	1	hubbard	PERSON
bptjm-46	278	1	annual	DATE
bptjm-46	279	1	69	CARDINAL
bptjm-46	279	2	2000	DATE
bptjm-46	279	3	373	CARDINAL
bptjm-46	280	1	23	CARDINAL
bptjm-46	281	1	lemmon	PERSON
bptjm-46	281	2	joseph schlessinger	PERSON
bptjm-46	283	1	141,7	DATE
bptjm-46	283	2	2010	DATE
bptjm-46	283	3	1117-34	DATE
bptjm-46	283	4	doi:10.1016/j.cell.2010.06.011	ORG
bptjm-46	283	5	24	CARDINAL
bptjm-46	284	1	fda	ORG
bptjm-46	285	1	25	CARDINAL
bptjm-46	286	1	zhen	PERSON
bptjm-46	286	2	y et al	PERSON
bptjm-46	289	1	21,11	CARDINAL
bptjm-46	289	2	2014	DATE
bptjm-46	289	3	491	CARDINAL
bptjm-46	289	4	doi:10.1038	ORG
bptjm-46	289	5	26	CARDINAL
bptjm-46	291	1	https://www.clinicaltrials.gov/ct2/results?cond=p	PERSON
bptjm-46	291	2	27	CARDINAL
bptjm-46	292	1	ocaña	ORG
bptjm-46	295	1	10,1 6132	DATE
bptjm-46	296	1	9 apr. 2020	TIME
bptjm-46	296	2	doi:10.1038	ORG
bptjm-46	297	1	chou	PERSON
bptjm-46	299	1	41	CARDINAL
bptjm-46	299	2	5	CARDINAL
bptjm-46	299	3	2021	DATE
bptjm-46	300	1	berkeley pharma tech journal	ORG
bptjm-46	300	2	116 29	DATE
bptjm-46	302	1	stf-31	NORP
bptjm-46	304	1	2018;41(5):485-494	CARDINAL
bptjm-46	306	1	wood te	PERSON
bptjm-46	309	1	2008;7(11):3546-3555	CARDINAL
bptjm-46	311	1	zakikhani, mahvash	PERSON
bptjm-46	313	1	66	DATE
bptjm-46	313	2	21, 2006	DATE
bptjm-46	314	1	10269–10273	DATE
bptjm-46	314	2	doi:10.1158/0008-5472.can-06-1500.	ORG
bptjm-46	315	1	32	CARDINAL
bptjm-46	316	1	mackie k. cb2 cannabinoid	PERSON
bptjm-46	318	1	2014;86(4):430	CARDINAL
bptjm-46	319	1	33	CARDINAL
bptjm-46	320	1	dowling	PERSON
bptjm-46	320	2	ryan j.o.	PERSON
bptjm-46	322	1	67	CARDINAL
bptjm-46	322	2	22, 2007	DATE
bptjm-46	323	1	doi:10.1158/0008-5472.can-07-2310	ORG
bptjm-46	324	1	34	CARDINAL
bptjm-46	324	2	25,	DATE
bptjm-46	324	3	2019	DATE
bptjm-46	325	1	n.d.	GPE
bptjm-46	326	1	mct4	PERSON
bptjm-46	327	1	justia	PERSON
bptjm-46	328	1	april 8	DATE
bptjm-46	328	2	2023	CARDINAL
bptjm-46	328	3	35	CARDINAL
bptjm-46	329	1	ben sahra i.	PERSON
bptjm-46	329	2	laurent k.	PERSON
bptjm-46	329	3	giuliano s.	PERSON
bptjm-46	329	4	larbret f.	PERSON
bptjm-46	329	5	ponzio g.	PERSON
bptjm-46	329	6	giorgetti-peraldi s.	ORG
bptjm-46	329	7	cormont m.	PERSON
bptjm-46	329	8	2	CARDINAL
bptjm-46	331	1	2010;70:2465–2475	CARDINAL
bptjm-46	331	2	36	CARDINAL
bptjm-46	332	1	chou	PERSON
bptjm-46	332	2	huang y	PERSON
bptjm-46	333	1	commun	PERSON
bptjm-46	333	2	lond	PERSON
bptjm-46	334	1	2021;41(5):414-431	CARDINAL
bptjm-46	335	1	37	CARDINAL
bptjm-46	336	1	goodwin pj	PERSON
bptjm-46	336	2	chen	PERSON
bptjm-46	336	3	gelmon ka	PERSON
bptjm-46	339	1	2022;327(20):1963-1973	DATE
bptjm-46	340	1	doi:10.1001	GPE
bptjm-46	340	2	38	CARDINAL
bptjm-46	341	1	yeung sl	PERSON
bptjm-46	341	2	luo s	PERSON
bptjm-46	342	1	2	CARDINAL
bptjm-46	344	1	2019;62(9):1638-1646	CARDINAL
bptjm-46	346	1	lee	PERSON
bptjm-46	346	2	hwang hk	PERSON
bptjm-46	346	3	kang cm	PERSON
bptjm-46	347	1	gemcitabine chemosensitivity	PERSON
bptjm-46	349	1	2021;44(6):1363-1371	CARDINAL
bptjm-46	350	1	huang y	PERSON
bptjm-46	351	1	commun	PERSON
bptjm-46	351	2	lond	PERSON
bptjm-46	352	1	2021;41(5):414-431	CARDINAL
bptjm-46	353	1	40.goldberg	CARDINAL
bptjm-46	354	1	kettle jg	PERSON
bptjm-46	354	2	lamont gm	PERSON
bptjm-46	354	3	4	CARDINAL
bptjm-46	356	1	2023;66(1):384-397	CARDINAL
bptjm-46	357	1	41	CARDINAL
bptjm-46	358	1	sr	ORG
bptjm-46	358	2	two	CARDINAL
bptjm-46	358	3	berkeley pharma tech journal	ORG
bptjm-46	358	4	117	CARDINAL
bptjm-46	360	1	2018;28(5):679-688.e4	DATE
bptjm-46	361	1	doi:10.1016/j.cmet.2018.08.021 42	ORG
bptjm-46	362	1	birsoy k.	PERSON
bptjm-46	362	2	wang t.	PERSON
bptjm-46	362	3	freinkman e.	PERSON
bptjm-46	362	4	abu-remailehm	PERSON
bptjm-46	362	5	sabatini d.m	PERSON
bptjm-46	365	1	2015;162:540–551	CARDINAL
bptjm-46	366	1	pmc	ORG
bptjm-46	366	2	43	CARDINAL
bptjm-46	367	1	u.s.	GPE
bptjm-46	368	1	n.d.	GPE
bptjm-46	369	1	two	CARDINAL
bptjm-46	370	1	april 8	DATE
bptjm-46	370	2	2023	CARDINAL
bptjm-46	370	3	44	DATE
bptjm-46	370	4	44	DATE
bptjm-46	371	1	anders s.	PERSON
bptjm-46	371	2	huber w. di�	PERSON
bptjm-46	373	1	2010;11	CARDINAL
bptjm-46	375	1	pmc	ORG
bptjm-46	375	2	45	CARDINAL
bptjm-46	378	1	3	CARDINAL
bptjm-46	378	2	9, 2010	DATE
bptjm-46	380	1	46	DATE
bptjm-46	381	1	wilson	PERSON
bptjm-46	381	2	yang	PERSON
bptjm-46	382	1	ptk787/zk 222584 (vatalanib	ORG
bptjm-46	383	1	j. 2013;13(5):410-416	PERSON
bptjm-46	383	2	doi:10.1038	ORG
bptjm-46	383	3	47	CARDINAL
bptjm-46	384	1	dowling rj	PERSON
bptjm-46	384	2	zakikhani m	PERSON
bptjm-46	384	3	pollak m	PERSON
bptjm-46	384	4	sonenberg n. metformin	PERSON
bptjm-46	386	1	2007;67(22):10804-10812	CARDINAL
bptjm-46	387	1	doi:10.1158/0008-5472.can-07-2310 48	ORG
bptjm-46	389	1	clin lung	PERSON
bptjm-46	390	1	2019;20(3):e413	CARDINAL
bptjm-46	390	2	doi:10.1016	PERSON
bptjm-46	390	3	49	CARDINAL
bptjm-46	391	1	marinello	ORG
bptjm-46	391	2	da silva tn	PERSON
bptjm-46	391	3	panis c	ORG
bptjm-46	393	1	2016;37(4):5337-5346	DATE
bptjm-46	394	1	015-4395	CARDINAL
bptjm-46	394	2	50	CARDINAL
bptjm-46	395	1	gilad y	PERSON
bptjm-46	395	2	lonard dm	PERSON
bptjm-46	395	3	o'malley	PERSON
bptjm-46	397	1	2021;13(4):669	CARDINAL
bptjm-46	398	1	2021	CARDINAL
bptjm-46	398	2	feb 7	DATE
bptjm-46	398	3	118	CARDINAL